OBIO
NASDAQ · Health Care
Orchestra Biomed Holdings In
$5.89
-0.06 (-1.01%)
Financial Highlights (FY 2026)
Revenue
42.57M
Net Income
-67,019,780
Gross Margin
99.4%
Profit Margin
-157.4%
Rev Growth
+111.7%
D/E Ratio
0.23
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 99.4% | 52.2% | 52.2% | 52.2% |
| Operating Margin | -154.7% | 14.5% | 14.7% | 14.2% |
| Profit Margin | -157.4% | 15.4% | 15.8% | 15.2% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 42.57M | 68.62M | 71.19M | 67.09M |
| Gross Profit | 42.33M | 35.85M | 37.19M | 35.05M |
| Operating Income | -65,876,275 | 9.92M | 10.44M | 9.52M |
| Net Income | -67,019,780 | 10.58M | 11.27M | 10.19M |
| Gross Margin | 99.4% | 52.2% | 52.2% | 52.2% |
| Operating Margin | -154.7% | 14.5% | 14.7% | 14.2% |
| Profit Margin | -157.4% | 15.4% | 15.8% | 15.2% |
| Rev Growth | +111.7% | -5.8% | -4.6% | -3.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 32.86M | 31.41M | 32.93M | 31.53M |
| Total Equity | 145.96M | 72.86M | 78.63M | 70.41M |
| D/E Ratio | 0.23 | 0.43 | 0.42 | 0.45 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -65,465,417 | 14.36M | 13.60M | 15.28M |
| Free Cash Flow | — | 6.20M | 6.53M | 6.19M |